Eagle Health Investments »

Soleno Therapeutics shares owned by Eagle Health Investments

Quarter-by-quarter ownership of Soleno Therapeutics (SLNO) shares owned by Eagle Health Investments from 13F filings

Historical chart of Eagle Health Investments investment in Soleno Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Soleno Therapeutics held by Eagle Health Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Soleno Therapeutics by Eagle Health Investments

Quarter filed Position value Share count Share price at filing
2025-12-31 $6.3M 135k 46.30

More positions owned by Eagle Health Investments

Argenx Se Sponsored Adr (ARGX)
Icon SHS (ICLR)
Natera (NTRA)
Insmed Com Par $.01 (INSM)
Illumina (ILMN)
Guardant Health (GH)
Neurocrine Biosciences (NBIX)
BioMarin Pharmaceutical (BMRN)
Fortrea Hldgs Common Stock (FTRE)
Bridgebio Pharma (BBIO)
Scholar Rock Hldg Corp (SRRK)
EXACT Sciences Corporation (EXAS)
Terns Pharmaceuticals (TERN)
Kymera Therapeutics (KYMR)
Compass Pathways Sponsored Ads (CMPS)

View all positions for Eagle Health Investments

Top funds holding Soleno Therapeutics

FMR
Henderson Group
BlackRock
Vanguard Group
venBio Select Advisor
State Street Corporation
Wellington Management Company
Nantahala Capital Management
Adage Capital Partners GP
Millennium Management
Commodore Capital
Braidwell
Geode Capital Management
Polar Capital Holdings
Woodline Partners

View all funds holding Soleno Therapeutics